Indian News


imf-040919_20jan20.jpg The International Monetary Fund on Monday cut the global growth forecasts for this year and next, mainly due to the weaker-than-expected expansion in India. Global growth for this year is projected at 3.3 percent, which is 0.1 percentage point less than the forecast made in October, the international lender said in the latest update to its World Economic Outlook.

fortyseven-jan20.jpg Shares of Forty Seven Inc. (FTSV) have been on a roll ever since the Company presented updated clinical data from its ongoing phase Ib trial evaluating Magrolimab in combination with Azacitidine for the treatment of myelodysplastic syndrome and acute myeloid leukemia last December.

pharma-071117_18jan20.jpg Shares of Bellicum Pharmaceuticals Inc. (BLCM) have gained more than 140% over the last 1 month as the Company gears up to present new data related to its autologous GoCAR-T product candidate BPX-601.

vir1-jan17.jpg Vir Biotechnology Inc. (VIR), which had a lackluster reception to its initial public offering, has gained 35 percent over the last 5 trading days but is still trading below its offering price of $20 per share.

vielabio-jan17.jpg Shares of Viela Bio Inc. (VIE), which have been hitting new highs, are up a whopping 100% since the Company's market debut on October 3, 2019.

lannett-jan17.jpg Shares of Lannett Company Inc. (LCI) have gained more than 20 percent over the last five trading days.

pharma-072817_16jan20.jpg Today's Daily Dose brings you news about the FDA panel's split verdict on DURECT's postoperative nonopioid pain relief depot, BioNTech's acquisition of Neon Therapeutics and the FDA designating Envafolimab as an orphan drug for the treatment of biliary tract cancer.

momenta-jan16.jpg Shares of Momenta Pharmaceuticals Inc. (MNTA) are up nearly 63 percent over the last one month as the Company approaches key data readouts across its clinical programs.

Follow RTT